M&A Deal Summary

Myriad Acquires Myriad Genetics - EndoPredict Business

On May 7, 2024, Myriad acquired life science company Myriad Genetics - EndoPredict Business from Eurobio Scientific

Acquisition Highlights
  • This is Myriad’s 5th transaction in the Life Science sector.
  • This is Myriad’s 5th transaction in the United States.
  • This is Myriad’s 1st transaction in Utah.

M&A Deal Summary

Date 2024-05-07
Target Myriad Genetics - EndoPredict Business
Sector Life Science
Buyer(s) Myriad
Sellers(s) Eurobio Scientific
Deal Type Divestiture

Target

Myriad Genetics - EndoPredict Business

Salt Lake City, Utah, United States
Myriad Genetics' EndoPredict Business offers a comprehensive suite of precision medicine tools for breast, prostate, ovarian, pancreatic, endometrial, and colon cancer. Myriad Genetics' EndoPredict Business is based in Salt Lake City, Utah.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Myriad

Salt Lake City, Utah, United States

Category Company
Founded 1991
Sector Life Science
Employees2,700
Revenue 753M USD (2023)
DESCRIPTION

Myriad is a molecular diagnostic company discovers and commercialize a transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad was founded in 1991 and is based in Salt Lake City, Utah.


DEAL STATS #
Overall 6 of 6
Sector (Life Science) 5 of 5
Type (Divestiture) 2 of 2
State (Utah) 1 of 1
Country (United States) 5 of 5
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-24 Myriad RBM

Austin, Texas, United States

Myriad RBM is a multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device (TruCulture®). Myriad RBM was founded in 2002 and is based in Austin, Texas.

Sell -

Seller(S) 1

SELLER

Eurobio Scientific

Les Ulis, France

Category Company
Founded 1997
Sector Healthcare Services
Employees300
Revenue 131M EUR (2023)
DESCRIPTION

Eurobio Scientific is involved in the manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology, and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, the group has established its own distribution network and a portfolio of proprietary products in the molecular biology field. Eurobio was founded in 1997 and is based in Les Ulis, France.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-13 Diagnostic International Distribution

Milan, Italy

Diagnostic International Distribution offers a range of specialized tests and instruments through exclusive distribution agreements. DID currently markets specific products from the Eurobio Scientific group by distributing the EurobioPlex range of PCR tests for infectious diseases. Diagnostic International Distribution was formed in 1946 and is based in Milan.

Buy -